TRCN-1023 clinical trials

FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS

This study is testing a new medicine called TRCN-1023 for people with Amyotrophic Lateral Sclerosis (ALS). It aims to see if the medicine is safe, how the body uses it, and if it could help slow down the disease. The medicine is given as a single injection near the spine.